/info/pages/search MenuClose Our Company About Us About Nestlé Health Science Advisory Board Key Investments Values and institutes Nutritional Therapies Newsroom Careers Health Management Aging Dysphagia Healthy aging Malnutrition Brain health Alzheimers Epilepsy Cancer / Oncology Cancer / Oncology My Cancer Nutrition Critical care / Surgery Adult Enteral Nutrition Critical Nutrition Bytes Major surgery Nutrition monitoring in the ICU Target Nutrition App Food Allergy Cow's Milk Protein Allergy Gastro intestinal Constipation Dysphagia Inflammatory bowel disease Irritable bowel syndrome Metabolic diseases Inborn Errors of Metabolism Obesity Obesity Pediatrics Cystic Fibrosis Failure to thrive / Growth delay GI Impairment My child with Cerebral Palsy Neurological disorders Our Brands Althéra • Alfaré • Alfamino BOOST® Compat Diabetisource AC Impact Isosource Meritene Modulen Novasource Nutren Optifast OptiFibre Peptamen Resource Resource ThickenUp SUSTAGEN Vitaflo Newsroom Press releases Events Videos × Results: Nestlé Health Science / Adult Enteral Nutrition / Therapeutic Fields / Critical Care Blood Glucose ADULT ENTERAL NUTRITION MENU ABOUT US BYTES BLOG CASE STUDIES CUSTOMER EXPERIENCE LIBRARY NEWS & EVENTS NUTRIENT SCIENCE PRODUCTS TARGET NUTRITION APP THERAPEUTIC FIELDS Critical Care Blood Glucose Back To Menu ASPEN 2018 – High protein, low carbohydrate, 100% whey based enteral formula is associated with lower blood glucose response in type 2 diabetes adult patients. A Systematic Scoping Review on the Clinical Burden of Hyperglycaemia in ICU Patients ESPEN 2017 – High protein, low carbohydrate, 100% whey based enteral formula is associated with lower blood glucose response in type 2 diabetes adult patients. Hypocaloric High-Protein Enteral Nutrition Improves Glucose Management in Critically Ill Patients nestle-monitoring-loaded